Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.
for
Advanced or Metastatic KRAS-mutant Tumor in Pancreatic Adenocarcinoma,
Location: Toronto, Dallas TX, San Antonio TX
Sponsor: Auricula Biosciences Inc.
Sex: All
Age: 18+
Code: NCT07148128
Phase1, Phase2, Recruiting
Phase II Biomarker Study of BND-22 in Combination With Cemiplimab in Solid Tumors
for
Solid Tumors
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06651593
Phase2, Recruiting
PET [89Zr]DFO-starPEG in Solid Tumors
for
Solid Tumor, Solid Carcinoma, Soft Tissue Lesion
Location: San Francisco CA
Sponsor: Robert Flavell, MD, PhD
Sex: All
Age: 18+
Code: NCT06894745
Phase1, Recruiting
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
for
Metastatic Solid Tumor, Recurrent Solid Tumor,
Location: Boston MA, New York NY, Cleveland OH, Grand Rapids MI,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06465069
Phase1, Recruiting
A Study of HS-20110 in Participants With Advanced Solid Tumors
for
Solid Tumors
Location: Fairfax VA, Tamarac FL, Huntersville NC, Fort Wayne IN,
Sponsor: Hansoh BioMedical R&D Company
Sex: All
Age: 18+
Code: NCT06892379
Phase1, Recruiting
Interested in new solid tumor trials?
Get alerts for new trials in your area by subscribing now
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
for
Advanced Solid Tumors, Malignant Neoplasm
Location: Hackensack NJ, Richmond VA, Miami FL, Birmingham AL,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06818643
Phase1, Phase2, Recruiting
A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid Tumors
for
Solid Tumors
Location: New Brunswick NJ, Washington D.C. DC, Orlando FL,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT07123103
Phase1, Recruiting
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors, Advanced Breast Cancer
Location: Boston MA, New Haven CT, Fairfax VA, Huntersville NC,
Sponsor: Ensem Therapeutics
Sex: All
Age: 18+
Code: NCT06993844
Phase1, Phase2, Recruiting
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)